Treatment Outcome and Relapse with Short-term Oral Terbinafine (250 mg/day) in Tinea Pedis

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Treatment outcome and relapse with short-term oral terbinafine (250 mg/day) in tinea pedis.

A total of 168 patients with tinea pedis, but without onychomycosis, were treated with 1 cycle of terbinafine (TBF) (1 cycle: defined as 250 mg/day for 1 week). KOH preparation for direct microscopy was performed 4, 8 and 12 weeks after starting therapy to determine if testing was positive for tinea. Patients with no negative results on KOH examination or no evidence of obvious clinical improve...

متن کامل

Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.

Terbinafine, a synthetic allylamine, exerts fungicidal activity against dermatophytes, the causative pathogens of tinea pedis. As proven in numerous clinical trials, tinea pedis can be effectively and safely treated by topical terbinafine. In fact, a 1-week application of terbinafine 1% cream eradicated fungal pathogens at least as effectively as 4-week treatment courses with topical azole deri...

متن کامل

Comparison of terbinafine and clotrimazole in treating tinea pedis.

OBJECTIVE To compare the efficacy and safety of terbinafine 1% cream and clotrimazole 1% cream in the treatment of tinea pedis. DESIGN Multicentre, double blind parallel group study. SETTING 32 general practices and one hospital. PATIENTS 256 patients with mycologically confirmed tinea pedis. Of the 211 patients evaluable, 107 were randomised to terbinafine (75 male, 32 female; mean (rang...

متن کامل

Comparison between Fluconazole and Terbinafine in the treatment of Tinea corporis and Tinea cruris

Objectives: This study aimed to compare the therapeutic efficacy of Terbinafine andFluconazole in terms of mycological cure in the treatment of Tinea corporis and Tineacruris. Method: In this clinical trial, 30 patients with T. corporis and T .cruris wereselected. Patients were divided into two groups by random selection. The first group wastreated with Fluconazole 150 mg weekly for four weeks ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Nippon Ishinkin Gakkai Zasshi

سال: 2005

ISSN: 0916-4804,1882-0476

DOI: 10.3314/jjmm.46.285